Compare BioNTech SE - ADR (BNTX) vs Enphase Energy Inc (ENPH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Enphase Energy Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Enphase Energy Inc trades at $43.22 (market cap $5.59B). The key difference: BioNTech SE - ADR is far larger — about 4.2× Enphase Energy Inc's market cap, and Enphase Energy Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | ENPH | |
|---|---|---|
Market Cap | $23.31B | $5.59B |
Sector | Health | Technology |
52-Week High | $119.34 | $72.33 |
52-Week Low | $83.89 | $26.12 |
Enterprise Value | $6.60B | $5.23B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Enphase Energy (ENPH) trades at $40.92, down 2.27% on the day, with a mixed technical picture showing a bullish moving average signal but neutral oscillators. Recent Q2 2026 earnings matched estimates but revenue declined 19.6% year-over-year, reflecting ongoing challenges in U.S. residential demand. The company is expanding its battery and commercial segments, with new product launches like the IQ Battery 10C aiming to drive recovery. Analyst consensus is a 'Buy' with a $45.37 price target, implying potential upside from current levels.
Outlook remains cautious but opportunistic; ENPH's valuation multiples are elevated (P/E 41.88, P/S 4.25), requiring earnings normalization for sustained gains. Key risks include cyclical solar demand, interest rate sensitivity, and competitive pressures. Near-term catalysts hinge on execution in storage and international markets, with the stock offering leverage to a sector rebound if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →
